ClinicalTrials.govpublic full text
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
autoimmune rheumatic diseases, pneumococcal vaccine, methotrexate, pcv20, immunogenicity, vaccination, rheumatology, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851443
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.